The KIR MLPA assay can accurately determine an individual’s KIR genotype in a highly efficient manner, allowing routine KIR genotyping in transplantation programs and offering the opportunity to increase the success rates of transplantation or graft-versus-leukemia effects. Here, KIR3DL1 is linked to leukemia.